ADME Flashcards

1
Q

Lipinski’s rule (rule of 5)

A
  • H bond donor <5
  • H-bond acceptor <10
  • MW < 500
  • cLogP <5
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain Lipophilicity

A

Tendency of a compound to partition into a non-polar lipid matrix versus an aqueous
Traditionally, octanol and water are used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Explain logP

A

Log10 of the partition coefficient if the compound in organic/water layers, where all the molecules are neutral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain LogD

A

Log10 of the distribution coefficient if the compound in organic/water layers at a specified pH. Molecules might be ions or neutral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain pKa

A

Compound’s ionizability in an aqueous solution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Solubility is determined by:

A
  • Compound structure
  • State (solid/liquid)
  • Solvent (type, pH, temperature)
  • Measurement methods
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Solubility is affected by:

A

Physicochemical properties:

  • lipophilicity
  • size
  • pKa
  • crystal lattice energy (crystal stacking, meeting point)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the modification strategies to improve solubility?

7

A
  • Addition is ionizable groups
  • Reduction of LogP
  • Addition of H-bonds
  • Addition of polar groups
  • Reduction of MW
  • Out-of-plane substitution
  • Construction of a prodrug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the modification strategies for improving dissolution rate?
(4)

A
  • Reduce the particle size
  • Prepare am oral solution
  • Formulation with surfactants
  • Prepare a salt form
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How much of potential drugs are excluded by the blood-brain barrier when going through the brain?

A

As much as 98%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the efflux?

A

It is the transport of a molecule out of a cell (for example with p-glycoprotein, Pgp)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Structure modifications strategies to improve brain penetration:
(6)

A
  • Reduce Pgp efflux
  • Reduce number of H-bond
  • Increase lipophilicity
  • Reduce MW
  • Replace carboxylic groups
  • Add intramolecular H-bonds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the two phases on metabolism and what is their mechanism?

A

Phase 1: modifications of the molecular structure

Phase 2: addition of polar groups to the molecular structure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which ADME parameters does metabolism affect?

A

It increases clearance, reduces exposure, and is a major cause of low bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is presystemic/first pass clearance?

A

It is when a drug is metabolised prior to reaching systemic circulation. It can occur in the gut and liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What kind of interaction can occur when two molecules are co-injected?

A

One drug can inhibit the metabolism of the other. This could lead to toxic effects

17
Q

What are the common phase 1 metabolic reactions?

A

Aliphatic oxidation, aromatic oxidation, alcohol oxidation, dehydrogenation, epoxidation, (N,S,O)-dealkylation
Réductions can also occur

18
Q

What moiety can be added during phase 2 metabolism?

A

Glucuronic acid

The mechanism is called glucuronidation

19
Q

Other than glucuronidation, what other polar moieties can be added during phase 2 metabolism?

A

Sulfations, acetylation, glycination and methylation can also occur

20
Q

What is the main effect of metabolic stability?

A

It affects pharmacokinetics (PK)

21
Q

The half-life determines the dose regimen on how…

A

How often the drug must be administered

22
Q

The oral bioavailability determines the dose regimen on how….

A

How much of the drug should be administered

23
Q

Inhibition of the P450 cytochrome family are part of phase … metabolism

A

Phase 1 metabolism

24
Q

What are the structure modification strategies for phase 1 metabolism?
(8)

A
  • Block the metabolite site by adding Fluorine
  • Block the metabolite site by adding other blocking groups
  • Remove labile functional groups
  • Cyclization
  • Change ring size
  • Change chirality
  • Reduce lipophilicity
  • Replace unstable groups
25
What king of blocking groups can be added to block phase 1 metabolism?
Chlorine, but also more bulky aliphatic groups
26
What are the structure modification strategies for phase 2 metabolism? (3)
- Introduce electron-withdrawing groups and steric hindrance - Change phenolic hydroxyl to cyclic urea or thiourea - Change phenolic hydroxyl to prodrug
27
What is a bioisostere?
It is a chemical substituent with similar physical/chemical properties. It produces similar biological properties
28
Plasma stability is important because...
Hydrolysis in plasma can be a major cause of compound clearance
29
Which functional groups are susceptible to plasma degradation? (6)
Esters, amides, carbamates, lactams, lactones, sulfonamides
30
What kind of approach can take advantage of plasma reactions?
A prodrug approach; typically, esters are prepared, and activated through hydrolysis
31
What are antedrugs?
Antedrugs are active locally but rapidly degrade to inactive compounds once they reach the bloodstream.
32
What is the purpose of antedrugs?
It is to reduce side effects by minimising systemic toxicity of the drug
33
What are the structure modification strategies to improve plasma stability? (3)
- Substitute an amide for an ester - Increase steric hindrance - Electron withdrawing groups decrease plasma stability (for antedrugs)
34
During the drug discovery process, drugs are exposed to many solutions:
- Organic solvents - Aqueous buffers - Bioassay buffers - Dosing solutions - GI tract
35
What is an excipient?
It is a secondary substance in a medication that can help stabilise/confer a therapeutic of the drug. It doesn’t react with the active drug
36
What are the structure modification strategies to improve solution stability? (4)
- Eliminate/modify unstable groups - Add an electron withdrawing group - Isosteric replacement of labile functional group - Increase steric hindrance
37
What are the applications of solution stability data? | 7
- Provide an early alert to liabilities - Selection of conditions for compound purification - Develop structure-stability relationship - Diagnose poor in vivo bioassay performance - Diagnose poor in vivo performance - Prioritize compound for in vivo animal studies - Structure elucidation of solution stability products (using LC-MS) guides synthetic optimization
38
What can reduce in vivo exposure in the stomach/intestine?
Low pH and enzymatic hydrolysis
39
How does a software calculate the LogP of a new molecule?
By breaking up the structure in substructures where the value is known, and then adding all these values